Advertisement
Michael A. Mussallem, Edwards Lifesciences' chairman and CEO, is scheduledto speak to conference attendees at 4:30 p.m. PT. A live webcast of thepresentation will be available to all interested parties on the EdwardsLifesciences investor relations website athttp://www.edwards.com/InvestorRelations/EventCalendar.htm. An archivedversion of the webcast will be available later that day on the Edwardsinvestor relations website in the News and Events section.
Advertisement
About Edwards Lifesciences
Edwards Lifesciences, a leader in advanced cardiovascular diseasetreatments, is the number-one heart valve company in the world and the globalleader in acute hemodynamic monitoring. Headquartered in Irvine, Calif.,Edwards focuses on specific cardiovascular disease states including heartvalve disease, peripheral vascular disease and critical care technologies. Thecompany's global brands, which are sold in approximately 100 countries,include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNTMagna and Swan-Ganz. Additional company information can be found athttp://www.edwards.com.
Edwards and FloTrac are trademarks of Edwards Lifesciences Corporation.Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNTMagna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and areregistered in the United States Patent and Trademark Office.
SOURCE Edwards Lifesciences Corporation
